Probing characteristics of cancer cells cultured on engineered platforms simulating different microenvironments
Source abstract
Abstract
In this study, we demonstrate cell culture platforms that can provide a microenvironment similar to in vivo conditions so that in vivo-compatible drug testing results can be obtained from the in vitro experiments. To realize such in vivo microenvironment-mimetic platforms, different culture platforms such as a three-dimensional (3D) cell aggregate film, fluidic environment within a microfluidic system or extracellular matrix (ECM) coating were established. The tumor cell growth rate and sensitivity to doxorubicin (DOX) were studied using the glioblastoma cell line T98G. When 3 D spheroids were cultured, they grew significantly slower than under other culture conditions. When the cells were treated with DOX, the anticancer drug could not efficiently penetrate the 3 D spheroids to inhibit cell growth. When cultured on the Matrigel-coated culture vessel, T98G cells grew even in the presence of DOX, demonstrating chemoresistance. Nonetheless, in the 2D culture plate and in the microfluidic chip, cell growth decreased with DOX treatment and the binding ability was lost. These results indicate that the cells reacted differently to the same anticancer drug depending on the culture microenvironment. We believe that the development of a more physiologically relevant tumor cell culture platform will lead to more reliable antitumor drug responses.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: 3D Printing in Biomedical Research · Innovative Microfluidic and Catalytic Techniques Innovation · Microfluidic and Bio-sensing Technologies
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
School of Integrative Engineering, Chung-Ang University
Center for BioMicrosystems, Brain Science Institute, Korea Institute of Science and Technology (KIST)
Division of Bio-Medical Science and Technology, KIST School, Korea University of Science and Technology (UST)
Funding
National Research Foundation of Korea · Ministry of Science and ICT · Ministry of Trade, Industry & Energy
References (48)
Show source-provided references
1. 10.1088/1758-5082/4/3/03500110.1088/1758-5082/4/3/035001 ↗
2. 10.1016/S0167-6296(02)00126-110.1016/S0167-6296(02)00126-1 ↗
3. 10.1016/j.jhealeco.2016.01.01210.1016/j.jhealeco.2016.01.012 ↗
4. 10.1177/02611929090370010810.1177/026119290903700108 ↗
5. 10.1016/j.jval.2013.08.90310.1016/j.jval.2013.08.903 ↗
6. 10.1177/02611929080360050810.1177/026119290803600508 ↗
7. 10.1038/nbt.278610.1038/nbt.2786 ↗
8. 10.1038/clpt.2009.29510.1038/clpt.2009.295 ↗
9. 10.1038/clpt.2010.28610.1038/clpt.2010.286 ↗
10. 10.1038/nrd147010.1038/nrd1470 ↗
11. 10.1017/S096318011500007910.1017/S0963180115000079 ↗
12. 10.1038/477526a10.1038/477526a ↗
13. 10.1038/nrd337510.1038/nrd3375 ↗
14. Mak IWY, Evaniew N, Ghert M. Lost in translation: animal models and clinical trials in cancer treatment. Am J Transl Res. 2014;6:114–118.
15. 10.1634/theoncologist.2008-017410.1634/theoncologist.2008-0174 ↗
16. 10.1038/nrd425310.1038/nrd4253 ↗
17. 10.1016/j.ccr.2005.05.02410.1016/j.ccr.2005.05.024 ↗
18. 10.1007/BF0262367510.1007/BF02623675 ↗
19. 10.1002/adhm.20150042710.1002/adhm.201500427 ↗
20. 10.1038/nature0505810.1038/nature05058 ↗
21. 10.1039/b921695b10.1039/b921695b ↗
22. 10.1016/j.addr.2015.10.00710.1016/j.addr.2015.10.007 ↗
23. 10.1002/jcb.2115910.1002/jcb.21159 ↗
24. 10.1038/sj.onc.120631510.1038/sj.onc.1206315 ↗
25. 10.1007/s00280-008-0881-910.1007/s00280-008-0881-9 ↗
26. 10.1038/onc.2008.27110.1038/onc.2008.271 ↗
27. 10.1021/acsbiomaterials.5b0017210.1021/acsbiomaterials.5b00172 ↗
28. 10.1016/j.jconrel.2012.04.04510.1016/j.jconrel.2012.04.045 ↗
29. 10.1016/S0021-9258(18)47058-510.1016/S0021-9258(18)47058-5 ↗
30. 10.1021/acsnano.6b0713410.1021/acsnano.6b07134 ↗
31. 10.1038/nm90910.1038/nm909 ↗
32. 10.1002/pmic.20090075810.1002/pmic.200900758 ↗
33. 10.4161/cbt.2135310.4161/cbt.21353 ↗
34. 10.1016/S1040-8428(00)00086-X10.1016/S1040-8428(00)00086-X ↗
35. 10.1158/1078-0432.CCR-08-239210.1158/1078-0432.CCR-08-2392 ↗
36. 10.3109/21691401.2014.96882010.3109/21691401.2014.968820 ↗
37. 10.1080/21691401.2017.139700110.1080/21691401.2017.1397001 ↗
38. 10.1080/21691401.2017.137428210.1080/21691401.2017.1374282 ↗
39. 10.2147/IJN.S2.2.26510.2147/IJN.S2.2.265 ↗
40. 10.1038/ncomms371810.1038/ncomms3718 ↗
41. 10.1038/nrc306410.1038/nrc3064 ↗
42. 10.1016/j.bbamem.2008.11.00510.1016/j.bbamem.2008.11.005 ↗
43. 10.31887/DCNS.2015.17.4/jpanksepp10.31887/DCNS.2015.17.4/jpanksepp ↗
44. Akhtar A. Animals and public health: why treating animals better is critical to human welfare. Choice: Curr Rev Acad Libraries 2012;50:515.
45. 10.7150/ijms.552910.7150/ijms.5529 ↗
46. Ehrmann RL, Gey GO. The growth of cells on a transparent gel of reconstituted rat-tail collagen. J Natl Cancer Inst. 1956;16:1375–1403.
47. 10.1038/nbt.298910.1038/nbt.2989 ↗
48. 10.1016/0167-6296(91)90001-410.1016/0167-6296(91)90001-4 ↗